• Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • Executive Briefs
    Sep. 16, 2025

    The Service Provider Health Check is a quarterly report that assesses leading IT-BP and engineering providers’ financial and operational health. It equips enterprises with key insights for RFP evaluations, contract negotiations, and risk management. In this…
  • Executive Briefs
    Aug. 07, 2025

    The Service Provider Health Check is a quarterly report that assesses leading IT-BP and engineering providers’ financial and operational health. It equips enterprises with key insights for RFP evaluations, contract negotiations, and risk management. In this…
  • Quarterly Earnings Analysis
    Dec. 17, 2024

    Everest Group’s Quarter Earnings Analysis reports deliver in-depth assessments of providers’ quarterly financial performance from a financial analyst’s perspective. They consider publicly available disclosures as well as proprietary models to offer a well-rounded evaluation of providers’…
  • Quarterly Earnings Analysis
    Dec. 04, 2024

    Everest Group’s Quarter Earnings Analysis reports deliver in-depth assessments of providers’ quarterly financial performance from a financial analyst’s perspective. They consider publicly available disclosures as well as proprietary models to offer a well-rounded evaluation of providers’…
  • Quarterly Earnings Analysis
    Dec. 02, 2024

    Everest Group’s Quarter Earnings Analysis reports deliver in-depth assessments of providers’ quarterly financial performance from a financial analyst’s perspective. They consider publicly available disclosures as well as proprietary models to offer a well-rounded evaluation of providers’…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Webinar
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Thematic Report
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Viewpoint
    Feb. 05, 2024

    In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Deciding betweenServiceNow’s dedicated and shared instances can be challenging for organizations. By comparing the options against seven key parameters ranging from organizational size and business process complexity to the cost of ownership and customization options, enterprises…

Items per page